Home » Stocks » KBLM

KBL Merger Corp. IV (KBLM)

Nov 9, 2020 - Stock symbol was changed to ATNF
Stock Price: $4.99 USD 0.00 (0.00%)
Updated Nov 6, 2020 4:00 PM EST

Stock Price Chart

Key Info

Market Cap 26.81M
Revenue (ttm) n/a
Net Income (ttm) -2.84M
Shares Out 5.47M
EPS (ttm) -0.65
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Nov 6, 2020
Last Price $4.99
Previous Close $4.99
Change ($) 0.00
Change (%) 0.00%
Day's Open 6.04
Day's Range 4.60 - 6.05
Day's Volume 160,754
52-Week Range 4.60 - 11.50

More Stats

Market Cap 26.81M
Enterprise Value 26.53M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 5.47M
Float n/a
EPS (basic) -0.65
EPS (diluted) -0.65
FCF / Share -0.30
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1,256
Short Ratio 1.11
Short % of Float n/a
Beta 0.18
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 6.54
Revenue n/a
Operating Income -1.28M
Net Income -2.84M
Free Cash Flow -1.32M
Net Cash 276,420
Net Cash / Share 0.05
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -2.55%
ROE -56.82%
ROIC -12.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-1.21-0.60-0.34
Net Income-
Shares Outstanding4.224.173.45
Earnings Per Share-
EPS Growth-600%-
Operating Cash Flow-1.45-0.79-0.50
Free Cash Flow-1.45-0.79-0.50
Cash & Equivalents0.550.270.43
Total Debt0.37--
Net Cash / Debt0.180.270.43
Book Value5.005.005.00
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name KBL Merger Corp. IV
Country United States
CEO Marlene R. Krauss

Stock Information

Ticker Symbol KBLM
Stock Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Unique Identifier NASDAQ: KBLM
IPO Date June 2, 2017


KBL Merger IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.